AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery

AMT Medical Raises $25M in Series B Funding

AMT Medical, an Ede and Utrecht, the Netherlands-based clinical-stage medtech company, raised $25M in Series B funding. The round was led by Bender Analytical Holding B.V. (BAH). Other investors Invest-NL, and the European Innovation Council (EIC) Oost NL and angels also participated. The company intends to use the funds to support new key initiatives, including […] The post AMT Medical Raises $25M in Series B Funding appeared first on FinSMEs.

AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery

www.amt-medical.nl See video Pioneering sutureless coronary bypass technology poised to eliminate open-chest procedures Sutureless anastomosis: Laser-assisted vessel connection via proprietary clip Beating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% cost reduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The Netherlands – April 17, 2025 – AMT Medical B.V., a clinical-s…